会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 벤조디아제핀 유도체의 제조방법
    • 制备苯二酸衍生物的方法
    • KR1020130077458A
    • 2013-07-09
    • KR1020110146178
    • 2011-12-29
    • 코오롱생명과학 주식회사
    • 최윤환신영균장원태최태근박상후
    • C07D243/14C07D243/26A61K31/5513A61P25/18
    • PURPOSE: A manufacturing method of the benzodiazepine derivative is provided to offer a simple production process and economic benefits not by using the expensive catalyst, and to safely mass-produce the high-yield of benzodiazepine derivative as there is not in danger of ignition or explosion. CONSTITUTION: A manufacturing method of the benzodiazepine derivative comprises the step of manufacturing the compound which is represented by the chemical formula 1 by the reduction reaction between a reducing agent and the compound represented by chemical formula 2. The above manufacturing method of the benzodiazepine derivative is performed by reacting the compound represented by chemical formula 2 with the reducing agent at a mol ratio of 1:0.5-1:10. The above reduction reaction occurs at 0 through 100°C. The above compound represented by chemical formula 2 is manufactured by cyclizing the compound represented by chemical formula 3 under the presence of base basic condition. The base is the one of the group comprised of sodium hydroxide and potassium hydroxide.
    • 目的:提供苯并二氮杂衍生物的制造方法,以提供简单的生产工艺和经济效益,而不是使用昂贵的催化剂,并且安全地大量生产高产量的苯并二氮杂衍生物,因为没有点燃或爆炸的危险 。 构成:苯并二氮杂衍生物的制造方法包括通过还原剂与化学式2所示的化合物的还原反应制造由化学式1表示的化合物的步骤。上述苯并二氮杂衍生物的制造方法为 通过使化学式2表示的化合物与还原剂以摩尔比为1:0.5-1:10反应而进行。 上述还原反应发生在0〜100℃。 由化学式2表示的上述化合物通过在碱性碱性条件的存在下使由化学式3表示的化合物环化来制备。 碱是由氢氧化钠和氢氧化钾组成的组中的一种。
    • 3. 发明公开
    • 아미노벤질아민의 제조방법
    • 制备氨基苯胺的方法
    • KR1020130077451A
    • 2013-07-09
    • KR1020110146169
    • 2011-12-29
    • 코오롱생명과학 주식회사
    • 신영균최윤환장원태김관희최태근박상후
    • C07C209/66C07C211/49C07B31/00
    • PURPOSE: A producing method of aminobenzylamine is provided to simplify production processes, and to mass-produce aminobenzylamine with high yield by not using an expensive catalyst. CONSTITUTION: A producing method of aminobenzylamine comprises the following steps: producing a compound denoted by chemical formula 2 by the substitution reaction between a compound denoted by chemical formula 3 and metallic azide; and a producing a compound denoted by chemical formula 1 by the reduction reaction between a nitro group of the compound denoted by the chemical formula 2 with an azide group. In the chemical formula 1: R1 is an alkyl group, an aryl group, a cycloalkyl group, and a heteroaryl group; l is a fixed number selected from 0-4; and R2 is selected from hydrogen, an alkyl group, an aryl group, a cycloalkyl group, and a heteroaryl group.
    • 目的:提供氨基苄胺的生产方法以简化生产工艺,并通过不使用昂贵的催化剂以高产率大量生产氨基苄胺。 构成:氨基苄胺的制造方法包括以下步骤:通过化学式3表示的化合物与金属叠氮化物之间的取代反应来制造由化学式2表示的化合物; 通过化学式2表示的化合物的硝基与叠氮基的还原反应来制造由化学式1表示的化合物。 在化学式1中:R 1是烷基,芳基,环烷基和杂芳基; l是0-4的固定数; 并且R 2选自氢,烷基,芳基,环烷基和杂芳基。
    • 4. 发明公开
    • 로수바스타틴의 제조방법 및 이에 사용되는 중간체 화합물
    • 用于制备罗哌沙星及其使用的中间体化合物的方法
    • KR1020130087153A
    • 2013-08-06
    • KR1020120008215
    • 2012-01-27
    • 코오롱생명과학 주식회사
    • 신영균정원택김관희최태근
    • C07D239/42A61K31/505A61K31/495
    • A61K31/495C07D239/42A61K31/505
    • PURPOSE: A method for preparing rosuvastatin is provided to obtain a large amount of high purity rosuvastatin using an intermediate compound without a separate purification process. CONSTITUTION: An intermediate compound is denoted by chemical formula 1. A method for preparing the intermediate compound comprises the steps of: reacting a compound of chemical formula 2 with a phosphine-based compound to prepare a compound of chemical formula 3; and reacting the compound of chemical formula 3 with a compound of chemical formula 4 under the presence of a base. A method for preparing a rosuvastatin compound of chemical formula 6 or a pharmaceutically acceptable salt thereof comprises the steps of: deprotecting the intermediate compound of chemical formula 1 under the presence of acid; hydrolyzing the treated compound under the presence of a base; and neutralizing and reacting with a pharmaceutically acceptable salt.
    • 目的:提供一种制备瑞舒伐他汀的方法,使用中间体化合物获得大量的高纯度瑞舒伐他汀,无需单独的纯化过程。 构成:中间体化合物由化学式1表示。制备中间体化合物的方法包括以下步骤:使化学式2的化合物与膦类化合物反应,制备化学式3的化合物; 并在碱的存在下使化学式3的化合物与化学式4的化合物反应。 制备化学式6的瑞舒伐他汀化合物或其药学上可接受的盐的方法包括以下步骤:在酸存在下使化学式1的中间体化合物脱保护; 在碱的存在下水解处理的化合物; 并中和并与药学上可接受的盐反应。